We made a couple of changes in the high growth portfolio today. We sold our position in Braze (580 shares) at $43.99. Braze has rallied considerably since we bought the position in late October. While Braze is a leading vendor in the customer engagement space, its valuation is no longer quite the relative bargain it was when…
As indicated in the weekly commentary, we wanted to add marginally to the net long position by opening a tiny investment in MongoDB and adding to the Procore position which had a weight of less than 2%. We wound up buying 60 shares of MongoDB at a price of $241.49. This cost $14,495. That…
This morning, we added another 900 shares of Pagaya to the portfolio. We bought the shares at $13.89, so the total consideration was $12,510. That brings our holding of Pagaya to 3200 shares, which is a weighting of a bit greater than 5%. Our margin balance goes to $268,025. As mentioned in the post regarding…
After considering my options overnight, I have decided to make some small additions to the High Growth portfolio-about half the level that I had initially considered. I bought 250 shares of Affirm @ $26.69 for a cost of $6680. The high growth portfolio now has 1450 shares of Affirm with a weight of 3.9%. I…
Sales of 1500 shares of UiPath and Sale of 150 shares of Dynatrace: Purchase of 300 shares of Nutanix, Purchase of 200 shares of GitLab As we had indicated, we have now eliminated UiPath from the portfolio. Its latest earnings report and guidance were very disappointing, and while the narrative may play out, we simply…
Sale of 100 Dynatrace and purchase of 200 shares of Confluent The market continues in a risk off pattern this Monday morning. Many stocks are still reacting to the perceived read-through from the results of MongoDB. As I tried to suggest, Mongo’s issues are grossly exaggerated, and really are not representative of what is actually…
Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…
Sale of 250 shares of Nutanix; Sale of 100 shares of Dynatrace; purchase of 150 shares of AppLovin; Purchase of 20 shares of CyberArk We made some changes to the high growth portfolio today. In general, my strategy is to hold positions long term. But sometimes, when I see tactical opportunities, I take them. I…
Sale of 50 shares of Crowdstrike; Purchase of 80 shares of CyberArk Very reluctantly, we decided to sell 25% of our Crowdstrike position today. Our sale price was $348.49 and the sale raided about $17,415. Crowdstrike shares have risen by more than 18% in the last 3+ weeks. That kind of performance is far greater…
Sale of 500 DT shares and purchase of 1000 shares of NU and 30 shares of Datadog We made some portfolio adjustments this morning. We sold 500 shares of Dynatrace at $47.79. We were not pleased with the company’s earnings report-particularly its forward guidance for ARR growth. After a couple of quarters of mentally making…